Skip to main content

Advertisement

SpringerLink
Log in

Plasma paraoxonase 1 arylesterase activity in d-galactose-induced aged rat model: correlation with LDL oxidation and redox status

  • Original Article
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

Objective

There is much evidence linking the involvement of oxidative stress in the pathogenesis of aging. Paraoxonase 1 (PON1) is an HDL-associated antioxidant enzyme that inhibits the oxidative modification of low-density lipoproteins (LDL). We have investigated the changes in plasma PON1 activity, LDL oxidation, radical scavenging activity and lipid peroxidation in d-galactose-induced aging rat model and also compared the results with 24-month naturally aged rats.

Method

Arylesterase activity of PON1, susceptibility of LDL for oxidation, plasma radical scavenging activity and plasma thiobarbituric acid reactive substances (TBARS) were measured in normal control rats (4-months-old control rats subjected to d-galactose-induced experimental aging, and 24-month-old naturally aged rats).

Results

There was a significant decrease in plasma PON1 arylesterase activity in both subcutaneous d-galactose-treated groups and 24-month-old aged rats (P < 0.05, for each). TBARS, an oxidative stress marker, was seen to increase in the experimental groups (P < 0.01). In both subcutaneous galactose-treated and naturally aged rats, there was a significant rise in plasma LDL oxidation (P < 0.05, for each). However, radical scavenging activity was decreased significantly (P < 0.01) in both groups, as compared to control.

Conclusions

The d-galactose-induced rat model of aging mimics the naturally aged rat with reference to PON1 arylesterase activity and susceptibility to LDL oxidation. The results emphasize the importance of PON1 with respect to aging and its association with redox balance of the body.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Kawakami K, Kadota J, Iida K, Shirai R, Abe K, Kohno S (1999) Reduced immune function and malnutrition in the elderly. Tohoku J Exp Med 187:157–171

    Article  CAS  PubMed  Google Scholar 

  2. Harman D (2006) Free radical theory of aging: an update: increasing the functional life span. Ann N Y Acad Sci 1067:10–21

    Article  CAS  PubMed  Google Scholar 

  3. Xu FB (1985) Sub-acute toxicity of d-galactose. In: Proceedings of the Second National Conference on Aging Research. Herbin China

  4. Zhang X, Li WB, Zhang BL (1990) Biochemical changes in d-galactose induced subacute toxicity and mimetic aging in mice. Chin J Pharmacol Toxicol 4:309–310

    Google Scholar 

  5. Zheng JY, Fu YR, Li M, Gao KS, Zhang XG (2009) Effect of LTA isolated from bifidobacteria on d-galactose-induced aging. Exp Gerontol 44:760–765

    Article  CAS  Google Scholar 

  6. Cui X, Zuo P, Zhang Q, Li X, Hu Y, Long J, Packer L, Liu J (2006) Chronic systemic d-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-alpha-lipoic acid. J Neurosci Res 84:647–654

    Article  CAS  PubMed  Google Scholar 

  7. Zhang Q, Li XK, Cui X, Zuo PP (2009) d-galactose injured neurogenesis in the hippocampus of adult mice. Neurol Res 27:552–556

    Article  Google Scholar 

  8. Yanar K, Aydın S, Cakatay U, Mengi M, Buyukpınarbas N, Atukeren P, Sitar ME, Sonmez A, Uslu E (2011) Protein and DNA oxidation in different anatomic regions of rat brain in a mimetic ageing model. Basic Clin Pharmacol Toxicol 109(6):423–433

    Article  CAS  PubMed  Google Scholar 

  9. Durrington PN, Mackness B, Mackness MI (2001) Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 21:473–480

    Article  CAS  PubMed  Google Scholar 

  10. Goswami B, Tayal D, Gupta N, Mallika V (2009) Paraoxonase: a multifaceted biomolecule. Clin Chim Acta 410:1–12

    Article  CAS  PubMed  Google Scholar 

  11. Van Lenten BJ, Wagner AC, Nayak DP, Hama S, Navab M, Fogelman AM (2001) High-density lipoprotein loses its anti-inflammatory properties during acute influenza infection. Circulation 103:2283–2288

    Article  PubMed  Google Scholar 

  12. Cherki M, Berrougui H, Isabelle M, Cloutier M, Koumbadinga GA, Khalil A (2007) Effect of PON1 polymorphism on HDL antioxidant potential is blunted with aging. Exp Gerontol 42:815–824

    Article  CAS  PubMed  Google Scholar 

  13. La Du BN (1996) Structural and functional diversity of paraoxonases. Nat Med 2:1186–1187

    Article  PubMed  Google Scholar 

  14. Nguyen DS, Sok DE (2003) Oxidative inactivation of paraoxonase 1, an antioxidant protein and its effect on antioxidant action. Free Radic Res 37:1319–1330

    Article  CAS  PubMed  Google Scholar 

  15. Berliner JA, Heinecke JW (1996) The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 20:707–727

    Article  CAS  PubMed  Google Scholar 

  16. Marathe GK, Zimmerman GA, McIntyre TM (2003) Platelet activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles. J Biol Chem 278:3937–3947

    Article  CAS  PubMed  Google Scholar 

  17. Mehdi MM, Rizvi SI (2012) Human plasma paraoxonase 1 (PON1) arylesterase activity during aging: correlation with susceptibility of LDL oxidation. Arch Med Res 43:438–443

    Article  CAS  PubMed  Google Scholar 

  18. Mehdi MM, Rizvi SI (2012) Plasma protein hydroperoxides during aging in humans: correlation with paraoxonase 1 (PON1) arylesterase activity and plasma total thiols. Arch Med Res 44:136–141

    Article  Google Scholar 

  19. Sheng-lang J, Yong-guang Y (2012) In vivo antioxidant activity of total flavonoids from indocalamus leaves in aging mice caused by d-galactose. Food Chem Toxicol 50:3814–3818

    Article  Google Scholar 

  20. Song X, Mingmin B, Diandong L, Yong LM (1999) Advanced glycation in d-galactose induced mouse aging model. Mech Ageing Dev 108:239–251

    Article  CAS  PubMed  Google Scholar 

  21. Ayub A, Mackness MI, Arrol S, Mackness B, Patel J, Durrington PN (1999) Serum paraoxonase after myocardial infarction. Arterioscler Thromb Vasc Biol 19:330–335

    Article  CAS  PubMed  Google Scholar 

  22. Schnitzer E, Pinchuk I, Bor A, Fainaru M, Samuni AM, Lichtenberg D (1998) Lipid oxidation in unfractionated serum and plasma. Chem Phys Lipids 92:151–170

    Article  CAS  PubMed  Google Scholar 

  23. Szabo MR, Iditoiu C, Chambre D, Lupea AX (2007) Improved DPPH determination for antioxidant activity spectrophotometric assay. Chem Paper 61:214–216

    Article  CAS  Google Scholar 

  24. Esterbauer H, Cheeseman KH (1990) Determination of aldehydic lipid peroxidation products: malondialdehyde and 4-hydroxynonenal. Methods Enzymol 186:407–413

    Article  CAS  PubMed  Google Scholar 

  25. Wei H, Li L, Song Q, Ai H, Chu J, Li W (2005) Behavioural study of the d-galactose induced aging model in C57BL/6Jmice. Behav Brain Res 157:245–251

    Article  CAS  PubMed  Google Scholar 

  26. Moyer JR Jr, Furtak SC, McGann JP, Brown TH (2009) Aging-related changes in calcium-binding proteins in rat perirhinal cortex. Neurobiol Aging 32:1693–1706

    Article  PubMed Central  PubMed  Google Scholar 

  27. Kong WJ, Wang Y, Wang Q, Hu YJ, Han YC, Liu J (2006) The relation between d-galactose injection and mitochondrial DNA 4834 bp deletion mutation. Exp Gerontol 41:628–634

    Article  CAS  PubMed  Google Scholar 

  28. Hua X, Lei M, Zhang Y, Ding J, Han Q, Hu G, Xiao M (2007) Long-term d-galactose injection combined with ovariectomy serves as a new rodent model for Alzheimer’ disease. Life Sci 80:1897–1905

    Article  CAS  PubMed  Google Scholar 

  29. Parameshwaran K, Irwin MH, Steliou K, Pinkert CA (2010) d-galactose effectiveness in modeling aging and therapeutic antioxidant treatment in mice. Rejuvenation Res 13:729–735

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Lei M, Hua X, Xiao M, Han Q, Hu G (2008) Impairments of astrocytes are involved in the d-galactose induced brain aging. Biochem Biophys Res Commun 369:1082–1087

    Article  CAS  PubMed  Google Scholar 

  31. Santanam N, Parthasarathy S (2007) Aspirin is a substrate for paraoxonase-like activity: implications in atherosclerosis. Atherosclerosis 191:272–275

    Article  CAS  PubMed  Google Scholar 

  32. Tsuzura S, Ikeda Y, Suehiro T, Ota K, Osaki F, Arii K, Kumon Y, Hashimoto K (2004) Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes. Metabolism 53:297–302

    Article  CAS  PubMed  Google Scholar 

  33. Jaouad L, Milochevitch C, Khalil A (2003) PON1 paraoxonase activity is reduced during HDL oxidation and is an indicator of HDL antioxidant capacity. Free Radic Res 37:77–83

    Article  CAS  PubMed  Google Scholar 

  34. Li WF, Furlong CE, Costa LG (1995) Paraoxonase protects against chlorpyrifos toxicity in mice. Toxicol Lett 76:219–226

    Article  CAS  PubMed  Google Scholar 

  35. Costa LG, Vitalone A, Cole TB, Furlong CE (2005) Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 69:541–550

    Article  CAS  PubMed  Google Scholar 

  36. Van Himbergen TM, van der Schouw YT, Voorbij HA, van Tits LJ, Stalenhoef AF, Peeters PH, Roest M (2008) Paraoxonase (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women. Atherosclerosis 199:408–414

    Article  PubMed  Google Scholar 

  37. Ozturk H, Gungor M, Yigit S, Tacyildiz H, Basinoglu F, Koldas M (2009) Effect of exercise on the paraoxonase activity. Clin Biochem 42:343–346

    Article  Google Scholar 

  38. La Du BN, Aviram M, Billecke S, Navab M, Primo-Parmo S, Sorenson RC, Standiford TJ (1999) On the physiological role(s) of the paraoxonases. Chem Biol Interact 14(119–120):379–388

    Google Scholar 

  39. Costa LG, Giordano G, Cole TB, Marsillach J, Furlong CE (2013) Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity. Toxicol 10(307):115–122

    Article  Google Scholar 

  40. Tavori H, Aviram M, Khatib S, Musa R, Nitecki S, Hoffman A, Vaya J (2009) Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects. Free Radic Biol Med 46:607–615

    Article  CAS  PubMed  Google Scholar 

  41. Mackness B, Durrington PN, Boulton AJM, Hine D, Mackness MI (2002) Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls. Eur J Clin Invest 32:259–264

    Article  CAS  PubMed  Google Scholar 

  42. Unal E, Uzun H, Kusaslan R, Dogan M, Genc H, Gunes P, Titiz I (2005) Serum paraoxonase (a high-density lipoprotein-associated lipophilic antioxidant) activity and lipid profile in experimental acute pancreatitis. Pancreas 31:84–87

    Article  CAS  PubMed  Google Scholar 

  43. Marchegiani F, Mara M, Oliveri F, Cardelli M, James RW, Boemi M, Franceschi C (2008) Paraoxonase 1: genetics and activities during aging. Rejuvenation Res 11:113–127

    Article  CAS  PubMed  Google Scholar 

  44. Polat D, Ezgi D, Ahmet B, Hakan Y (2006) Decreased serum paraoxonase 1 (PON1) activity: an additional risk factor for atherosclerotic heart disease in patients with PCOS? Hum Reprod 21:104–108

    Article  Google Scholar 

  45. Caroline AA, Michael IM, Sudhesh K, Andrew JB, Paul ND (1995) Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler Thromb Vasc Biol 15:1812–1818

    Article  Google Scholar 

  46. Jaouad L, de Guise C, Berrougui H, Cloutier M, Isabelle M, Fulop T, Payette H, Khalil A (2006) Age-related decrease in high-density lipoproteins antioxidant activity is due to an alteration in the PON1’s free sulfhydryl groups. Atherosclerosis 185:191–200

    Article  CAS  PubMed  Google Scholar 

  47. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN (1998) Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 101:1581–1590

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  48. Mackness B, Durrington PN, Mackness MI (1998) Review human serum paraoxonase. Gen Pharmacol 31:329–336

    Article  CAS  PubMed  Google Scholar 

  49. Rozenberg O, Aviram M (2006) S-Glutathionylation regulates HDL associated paraoxonase 1 (PON1) activity. Biochem Biophys Res Commun 351:492–498

    Article  CAS  PubMed  Google Scholar 

  50. Ates O, Azizi S, Alp HH, Kiziltunc A, Kocer I, Baykal O (2009) Decreased serum paraoxonase 1 activity and increased serum homocysteine and malondialdehyde levels in age-related macular degeneration. Tohoku J Exp Med 217:17–22

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are grateful to University Grants Commission, New Delhi for financial support in the form of grant F 37-392/2009 to SIR.

Conflict of interest

The authors declare no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Biochemistry, University of Allahabad, Allahabad, UP, 211002, India

    Dileep Kumar & Syed Ibrahim Rizvi

Authors
  1. Dileep Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Syed Ibrahim Rizvi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Syed Ibrahim Rizvi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kumar, D., Rizvi, S.I. Plasma paraoxonase 1 arylesterase activity in d-galactose-induced aged rat model: correlation with LDL oxidation and redox status. Aging Clin Exp Res 26, 261–267 (2014). https://doi.org/10.1007/s40520-013-0170-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40520-013-0170-2

Keywords

Search

Navigation